Live from the NIH registry
Studies recruiting near Oceanside right now
Top 25 of 711 recruiting studies, sorted by proximity — each links to its official registry page
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Francisco
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Scripps Clinic Torrey Pines — La Jolla, California (26.2 mi)
· Sponsor: Pfizer
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Headlands Research California, LLC — Escondido, California (14.8 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (26.2 mi)
· Sponsor: Salma Health, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Marcos — San Marcos, California (10.0 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
The Neurology Center of Southern California - Carlsbad Office — La Jolla, California (26.2 mi)
· Sponsor: AbbVie
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: Daiichi Sankyo
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Belly Pain, GI Health
N/A
Interventional 825 participants sought
Radicle Science Inc. — Del Mar, California (18.5 mi)
· Sponsor: Radicle Science
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: Kura Oncology, Inc.
Testing the Effectiveness of an Intervention That Aligns Circadian Rhythm With Daily Activities on Student Flourishing
Chronotypes and Health
N/A
Interventional 400 participants sought
UC San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Rady Children's Hospital, UCSD — La Jolla, California (26.2 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Solid Tumor, Adult, Triple Negative Breast Cancer
Phase 1
Interventional 60 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: BioEclipse Therapeutics
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
University of California San Diego — La Jolla, California (26.2 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Excell Research Inc — Oceanside, California (4.6 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Excell Research /ID# 270258 — Oceanside, California (4.6 mi)
· Sponsor: AbbVie
Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes
Prediabetes, Obesity (Body Mass Index >30 kg/m2)
N/A
Interventional 30 participants sought
UCSD Center for Healthy Eating and Activity Research (CHEAR — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 300 participants sought
Moores Cancer Center - UCSD Health — La Jolla, California (26.2 mi)
· Sponsor: Surgimab
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 2
Interventional 520 participants sought
University of California at San Diego — La Jolla, California (26.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Moores Cancer Center ( Site 0003) — La Jolla, California (26.2 mi)
· Sponsor: Merck Sharp & Dohme LLC
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-San Marcos — San Marcos, California (10.0 mi)
· Sponsor: NRG Oncology
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
UC San Diego Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Magenta Medical Ltd.